Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Derek J, Hei"'
Autor:
Andreas Kurtz, Stefanie Seltmann, Amos Bairoch, Marie-Sophie Bittner, Kevin Bruce, Amanda Capes-Davis, Laura Clarke, Jeremy M. Crook, Laurence Daheron, Johannes Dewender, Adam Faulconbridge, Wataru Fujibuchi, Alexander Gutteridge, Derek J. Hei, Yong-Ou Kim, Jung-Hyun Kim, Anja Kolb- Kokocinski, Fritz Lekschas, Geoffrey P. Lomax, Jeanne F. Loring, Tenneille Ludwig, Nancy Mah, Tohru Matsui, Robert Müller, Helen Parkinson, Michael Sheldon, Kelly Smith, Harald Stachelscheid, Glyn Stacey, Ian Streeter, Anna Veiga, Ren-He Xu
Publikováno v:
Stem Cell Reports, Vol 10, Iss 1, Pp 1-6 (2018)
Unambiguous cell line authentication is essential to avoid loss of association between data and cells. The risk for loss of references increases with the rapidity that new human pluripotent stem cell (hPSC) lines are generated, exchanged, and impleme
Externí odkaz:
https://doaj.org/article/41d7834985bb42c5878caa009fac3aaa
Autor:
Rohini Radia, Gene Uenishi, Maria H. Gilleece, Adrian Bloor, Laurie S. Larson, Diana Drier, James E. Griffin, Igor I. Slukvin, Amit R. Patel, Kilian Kelly, David T Yeung, John E.J. Rasko, Derek J. Hei
Publikováno v:
Nature Medicine. 26:1720-1725
The therapeutic potential of donor-derived mesenchymal stromal cells (MSCs) has been investigated in diverse diseases1, including steroid-resistant acute graft versus host disease (SR-aGvHD)2. However, conventional manufacturing approaches are hamper
Autor:
Cesar A. Keller, Thomas A. Gonwa, Abba C. Zubair, John M. Centanni, David O. Hodge, Derek J. Hei
Publikováno v:
Stem Cells Translational Medicine
Feasibility, tolerance, and safety of intravenous infusions of allogeneic mesenchymal stem cell (MSC) therapy in lung transplant recipients with bronchiolitis obliterans syndrome (BOS) are not well established. MSCs were manufactured, cryopreserved,
Autor:
Ian Streeter, Stefanie Seltmann, Anja Kolb Kokocinski, Geoffrey P. Lomax, Jeanne F. Loring, Glyn Stacey, Harald Stachelscheid, Laurence Daheron, Kelly P. Smith, Tohru Matsui, K. Bruce, Adam Faulconbridge, Wataru Fujibuchi, Michael Sheldon, Robert Müller, Jung-Hyun Kim, Marie-Sophie Bittner, Derek J. Hei, Johannes Dewender, Laura Clarke, Yong-Ou Kim, Anna Veiga, Amos Marc Bairoch, Andreas Kurtz, Amanda Capes-Davis, Helen Parkinson, Fritz Lekschas, Tenneille Ludwig, Jeremy M. Crook, Ren-He Xu, Nancy Mah, Alexander Gutteridge
Publikováno v:
Stem Cell Reports, Vol 10, Iss 1, Pp 1-6 (2018)
Stem Cell Reports
Stem Cell Reports, Vol. 10, No 1 (2018) pp. 1-6
Stem Cell Reports
Stem Cell Reports, Vol. 10, No 1 (2018) pp. 1-6
Unambiguous cell line authentication is essential to avoid loss of association between data and cells. The risk for loss of references increases with the rapidity that new human pluripotent stem cell (hPSC) lines are generated, exchanged, and impleme
Autor:
Jill M. Koch, John M. Centanni, Rudolf K. Braun, Marlowe W. Eldridge, Timothy A. Hacker, Derek J. Hei, Peiman Hematti, Eric G. Schmuck, Amish N. Raval
Publikováno v:
Stem Cells Translational Medicine
To study three-dimensional (3D) cryo-imaging to measure cell biodistribution and clearance after intravenous infusion, the authors established a lung injury model in rats. Human mesenchymal stem cells (hMSCs) labeled with QTracker were infused via ju
Autor:
Jaehyup Kim, Karl K. Vigen, Michael T. Tomkowiak, Denise J. Schwahn, Charles R. Hatt, Peiman Hematti, Eric G. Schmuck, Cathlyn Leitzke, Timothy A. Hacker, Jill M. Koch, Derek J. Hei, Amish N. Raval, Nicholas Hendren, John M. Centanni, Ying qi Zhao, Zhanhai Li
Publikováno v:
Journal of Cardiovascular Translational Research. 8:438-448
The aim of this study is to determine the effects of early intravenous (IV) infusion later followed by transendocardial (TE) injection of allogeneic mesenchymal stem cells (MSCs) following myocardial infarction (MI). Twenty-four swine underwent ballo
Autor:
Neehar Bhatia, Carol A. Emler, John M. Centanni, Glen Leverson, Diana Drier, Debra D. Bloom, David H. McKenna, Adrian P. Gee, Derek J. Hei, Robert Lindblad, Peiman Hematti
Publikováno v:
Cytotherapy. 17:140-151
Background aims The T-cell suppressive property of bone marrow–derived mesenchymal stromal cells (MSCs) has been considered a major mode of action and basis for their utilization in a number of human clinical trials. However, there is no well-estab
Autor:
David H. McKenna, Ping Jin, Adrian P. Gee, David F. Stroncek, Peiman Hematti, Jose A. Cancelas, Jiaqiang Ren, Timothy O'Brien, Sergei A. Kuznetsov, Pamela Gehron Robey, Myriam Armant, Shutong Liu, Derek J. Hei, Luis F de Castro, Jo Anna Reems, Leslie E. Silberstein, Georgina Shaw, Sara Civini, Ramesh C. Nayak
Publikováno v:
Scientific Reports
Human bone marrow stromal cells (BMSCs, also known as bone marrow-derived mesenchymal stem cells) are manufactured using many different methods, but little is known about the spectrum of manufacturing methods used and their effects on BMSC characteri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e0ae09e5c513fedc7797474df855c34
http://hdl.handle.net/10379/12473
http://hdl.handle.net/10379/12473
Autor:
Cliona M. Rooney, Larry A. Couture, Robert Lindblad, David Styers, Peiman Hematti, Laarni Ibenana, Myriam Armant, Deborah Wood, David H. McKenna, John E. Wagner, Adrian P. Gee, Derek J. Hei, Lisbeth A. Welniak, Traci Heath Mondoro, Leslie E. Silberstein
Publikováno v:
Transfusion. 55:674-679
Cell therapy products have become more sophisticated both in type and manufacturing complexity (1-3). As clinicians' and researchers' understanding of disease and cell mechanisms of action continue to grow, cell therapy products are being increasingl
Publikováno v:
Circulation Research. 114:1328-1345
Coronary artery disease with associated myocardial infarction continues to be a major cause of death and morbidity around the world, despite significant advances in therapy. Patients who have large myocardial infarctions are at highest risk for progr